Pharmacology (Medicine) papers
Pofolia’s corpus holds 98 papers from Pharmacology (Medicine) (1967–2026), each with a short summary. Below, the 20 most-cited, then the most recently added.
At a glance
- Most cited: Cognitive Therapy for Depression (2012, 9,720 citations).
- The 20 papers listed have 74,311 citations between them.
- 16 of the 17 with a known journal quartile appeared in a Q1 journal.
- 8 have a free full text (open access).
- Most frequent journals: Journal of Natural Products, Pain, Annals of Internal Medicine.
- Published between 2012 and 2020.
Most cited
Ranked by citation count. Because citations accumulate over time, this list naturally leans towards work published a few years ago; for where the field is now, see “recently added”. How to read the signals
Cognitive Therapy for Depression
PsycEXTRA Dataset · 2012 · 9,720 citations
Cognitive therapy (CT) for depression shows acute effects comparable to medication but offers enduring benefits after treatment cessation.
Natural Products as Sources of New Drugs over the Nearly Four Decades from 01/1981 to 09/2019
Journal of Natural Products · 2020 · Q1 · FWCI 476.48 · 6,724 citations · Open access
Natural products and their synthetic variations continue to be a vital source for new drug discovery, contributing significantly to approved therapeutic agents, particularly in cancer treatment.
Natural Products as Sources of New Drugs from 1981 to 2014
Journal of Natural Products · 2016 · Q1 · FWCI 650.22 · 5,873 citations
Natural products remain a vital source for new drug discovery, with 49% of approved anti-cancer small molecules and a significant portion of anti-infectives derived from or directly based on natural compounds between 1981 and 2014.
The revised International Association for the Study of Pain definition of pain: concepts, challenges, and compromises
Pain · 2020 · Q1 · SJR 2.00 · FWCI 325.91 · 4,928 citations
The IASP has revised its 40-year-old definition of pain to "An unpleasant sensory and emotional experience associated with, or resembling that associated with, actual or potential tissue damage," updating accompanying notes to clarify concepts.
Natural Products As Sources of New Drugs over the 30 Years from 1981 to 2010
Journal of Natural Products · 2012 · Q1 · FWCI 395.44 · 4,679 citations
Natural products remain a vital source for novel drug structures, with 48.6% of anti-cancer small molecules and a significant portion of anti-infectives derived from them between 1981-2010.
Comparative Efficacy and Acceptability of 21 Antidepressant Drugs for the Acute Treatment of Adults With Major Depressive Disorder: A Systematic Review and Network Meta-Analysis
The Lancet · 2018 · FWCI 67.49 · 3,496 citations · Open access
A comprehensive meta-analysis of 522 trials found that while all 21 antidepressants studied were more effective than placebo for acute major depressive disorder, differences in efficacy and acceptability varied significantly, particularly in head-to-head comparisons.
European Guidelines for Obesity Management in Adults
Obesity Facts · 2015 · Q1 · SJR 1.00 · FWCI 222.77 · 3,396 citations · Open access
New European guidelines emphasize obesity as a chronic disease requiring lifelong, multidisciplinary management, integrating diet, exercise, behavioral therapy, pharmacotherapy, and surgery.
Chronic pain as a symptom or a disease: the IASP Classification of Chronic Pain for the International Classification of Diseases (ICD-11)
Pain · 2018 · Q1 · SJR 2.00 · FWCI 106.66 · 3,308 citations
A new classification system for chronic pain, applicable across diverse settings, defines chronic pain as lasting over 3 months and categorizes it as either "chronic primary pain" (a disease in itself) or "chronic secondary pain" (a symptom of another disease).
Noninvasive Treatments for Acute, Subacute, and Chronic Low Back Pain: A Clinical Practice Guideline From the American College of Physicians
Annals of Internal Medicine · 2017 · Q1 · SJR 2.00 · FWCI 198.07 · 3,257 citations
For acute/subacute low back pain, nonpharmacologic treatments like heat, massage, or acupuncture are recommended first, with NSAIDs or muscle relaxants if medication is needed. For chronic low back pain, exercise and other nonpharmacologic therapies are the initial choice.
The global burden of low back pain: estimates from the Global Burden of Disease 2010 study
Annals of the Rheumatic Diseases · 2014 · Q1 · SJR 7.00 · FWCI 153.73 · 3,230 citations · Open access
Low back pain (LBP) is the leading cause of disability globally, ranking highest among 291 conditions studied for disability (YLDs) and sixth for overall burden (DALYs). Its global burden has significantly increased from 1990 to 2010.
antiSMASH 5.0: updates to the secondary metabolite genome mining pipeline
Nucleic Acids Research · 2019 · Q1 · SJR 8.00 · FWCI 355.67 · 3,133 citations · Open access
The antiSMASH 5.0 pipeline, a widely used tool for identifying microbial biosynthetic gene clusters, has been significantly updated with new detection rules for diverse secondary metabolites and improved analysis speed.
A systematic review of the global prevalence of low back pain
Arthritis & Rheumatism · 2012 · FWCI 24.95 · 3,019 citations
A systematic review of 165 studies found that low back pain is a major global health issue, with an estimated point prevalence of 11.9% and a 1-month prevalence of 23.2%.
Adverse Health Effects of Marijuana Use
New England Journal of Medicine · 2014 · Q1 · SJR 18.00 · FWCI 184.81 · 2,762 citations
Contrary to popular belief, marijuana use may pose significant health risks, despite its increasing legalization and perceived harmlessness.
Comprehensive Review on Alzheimer’s Disease: Causes and Treatment
Molecules · 2020 · Q1 · FWCI 136.59 · 2,686 citations · Open access
Alzheimer's disease (AD) is a multifactorial neurodegenerative disorder leading to dementia, with current treatments only managing symptoms, not curing or preventing the disease.
Prevalence of Chronic Pain and High-Impact Chronic Pain Among Adults — United States, 2016
MMWR Morbidity and Mortality Weekly Report · 2018 · Q1 · SJR 8.00 · FWCI 142.80 · 2,625 citations
In 2016, an estimated 20.4% (50 million) of U.S. adults experienced chronic pain, with 8.0% (19.6 million) suffering from high-impact chronic pain that frequently limits daily activities.
Acetylcholinesterase Inhibitors: Pharmacology and Toxicology
Current Neuropharmacology · 2013 · Q1 · SJR 1.00 · FWCI 54.34 · 2,556 citations · Open access
Acetylcholinesterase inhibitors, by blocking the breakdown of acetylcholine, are used therapeutically for neurodegenerative diseases and also act as toxins. This review details their pharmacology and toxicology, covering both reversible and irreversible types.
Antibiotics: past, present and future
Current Opinion in Microbiology · 2019 · Q1 · SJR 2.00 · FWCI 98.97 · 2,346 citations
Antibiotic discovery, which dramatically extended human lifespan, has declined since the mid-1950s, leading to a current antimicrobial resistance crisis.
RELIEVING PAIN IN AMERICA: A BLUEPRINT FOR TRANSFORMING PREVENTION, CARE, EDUCATION, AND RESEARCH
Journal of Pain & Palliative Care Pharmacotherapy · 2012 · Q3 · FWCI 185.76 · 2,208 citations
A comprehensive report from the National Academy of Sciences (via the Institute of Medicine) outlines a national blueprint to transform pain prevention, care, education, and research in America.
Taxonomy, Physiology, and Natural Products of Actinobacteria
Microbiology and Molecular Biology Reviews · 2016 · Q1 · SJR 3.00 · FWCI 122.50 · 2,197 citations · Open access
Actinobacteria are a vast and diverse phylum of Gram-positive bacteria crucial for biotechnology and medicine, producing approximately two-thirds of all naturally derived antibiotics and many other valuable compounds.
Cognitive impairment in depression: a systematic review and meta-analysis
Psychological Medicine · 2013 · Q1 · SJR 2.00 · FWCI 10.41 · 2,168 citations
Cognitive deficits in executive function, memory, and attention are core features of depression, persisting even after depressive symptoms remit.
Recently added
Chromones: Important Templates for Pesticide Development
ACS Agricultural Science & Technology · 2026 · Q1
Chromone derivatives are versatile scaffolds with demonstrated antifungal, insecticidal, and nematicidal activities, making them promising templates for developing new pesticides.
Use of cannabidiol products in Canada, United States, Australia, Aotearoa New Zealand, United Kingdom and Germany: products, sources and reasons for use
International Journal of Drug Policy · 2026 · Q1 · SJR 1.00
CBD-only product use was highest in the US and lowest in Australia/New Zealand, with oils and edibles being the most common forms, and pain, anxiety, and depression the primary reasons for use across six surveyed countries (n=79,644).
Ganoderma Lucidum Polysaccharides Potentiate Low‐Dose Gemcitabine Against 4T1 Breast Tumors, Associated With Immune Activation and Gut Microbiota Remodeling
Molecular Carcinogenesis · 2026 · Q2 · SJR 1.00
Combining Ganoderma lucidum polysaccharides (GLP) with low-dose gemcitabine (GEM) synergistically inhibited 4T1 breast tumor growth in mice, outperforming either treatment alone.
Mapping and monitoring land usage changes of gum Arabic belt in armed conflict-disturbed areas to support sustainable management of the belt
Scientific Reports · 2026 · Q1
Vegetation recovery in Sudan's Gum Arabic Belt (GAB) has increased significantly between 2020-2023, correlated with land abandonment due to armed conflict and displacement, despite a notable dip in gum yield in 2005.
Prevalence and associated factors of cognitive impairment in patients with major depressive disorder: a cross-sectional study in Vietnam
International Journal of Psychiatry in Clinical Practice · 2026 · Q2
Cognitive impairment affects 72.7% of major depressive disorder (MDD) outpatients in Vietnam, with verbal fluency, abstraction, and delayed recall most impacted.
(±)-Nigronetides A−D and Nigronetides E−H, Complex Polyketides Produced by the Marine-Derived Fungus Nigrograna sp. M13
Journal of Natural Products · 2026 · Q1
Eight complex polyketides, including three novel carbon skeletons, were isolated from the marine fungus Nigrograna sp. M13.
Comparison of Caffeine Content in Coffee and Yerba Mate Prepared According to Traditional Consumption Methods in Argentina
Beverages · 2026 · Q2
Espresso-based coffee preparations in Argentina deliver significantly higher caffeine concentrations (225.0–533.9 mg/100 mL) than filter coffee, instant coffee, or mate cocido, with yerba mate providing 243-273 mg total caffeine over 15 servings.
Drimane-Pyrone-Type Meroterpenoids and Co-Isolated Compounds from the Deep-Sea Fungus Penicillium rubens MABC05 and Their Anti-Ferroptotic and Cytotoxic Activities
Marine Drugs · 2026 · Q1 · SJR 1.00
A deep-sea fungus yielded 17 compounds, including six new drimane-pyrone meroterpenoids and a new hybrid molecule. Compound 15 potently inhibited ferroptosis (a cell death pathway linked to kidney injury) with an EC50 of 12.8 μM, while compounds 11 and 16 showed cytotoxicity against breast cancer cells with IC50s of 4.3 and 8.4 μM, respectively.
Journals in this field
The journals that publish most of this field’s papers. Quartile (Q1–Q4), SJR and h-index are from SCImago Journal Rank; “in this field” is how many of the journal’s pooled papers belong here. What is a Q1 journal? · What is the h-index?
| Journal | Quartile | SJR | h-index | In this field | Summaries |
|---|---|---|---|---|---|
| Nucleic Acids Research | Q1 | 8.00 | 714 | 4 | 43 |
| Journal of Natural Products | Q1 | — | 173 | 4 | 4 |
| Pain | Q1 | 2.00 | 314 | 3 | 10 |
| International Journal of Molecular Sciences | Q1 | 1.00 | 365 | 3 | 45 |
| Molecules | Q1 | — | 296 | 3 | 33 |
| New England Journal of Medicine | Q1 | 18.00 | 1275 | 2 | 376 |
| JAMA Psychiatry | Q1 | 5.00 | 429 | 2 | 15 |
| Journal of Medicinal Chemistry | Q1 | 1.00 | 329 | 2 | 11 |
Every journal in Pharmacology (Medicine) (Q1–Q4) →
Add this field to your daily feed
Pick your interests and new work in your area arrives every day, summarised. Full summaries live in the app.
Open the app